This is the third competing renewal of our Program Project Grant, "Drugs of Abuse: Role of Protein Phosphorylation" (DA010044), which was initially funded in 1996 and most recently in 2006. The grant has been highly successful based on research productivity and initiation of new research projects. The overall objective of the Program Project Grant remains the same as the original, namely, to elucidate the molecular basis of the actions of drugs of abuse, particularly psychostimulants, in the dorsal striatum and nucleus accumbens. The Program Project Grant is organized into three Projects, a Scientific Core and an Administrative Core. The Administrative Core will support the integration of the researchers and institutions involved in the Program Project Grant. The main goal of the Scientific Core is to provide research and technical support for all of the Projects. Responsibilities of the Scientific Core will include the creation, characterization, and breeding of genetically altered animals;the design and execution of yeast two-hybrid studies;the production and maintenance of key reagents stocks and new reagents;and the performance of certain routine tasks required to accomplish the studies described in Projects 1-3. Project 1, "Cell type- and region-specific studies of psychostimulants and dendritic spines" will focus on the role of Cdk5 and WAVE1, regulators of actin dynamics in the dendritic spines. Project 2, "The role of the mGluR5/CK1-CK2/DARPP-32 pathway in mediating the effects of psychostimulants," will extend previous studies of novel signaling pathways that regulate DARPP-32 function. Project 3, "Striatal Phosphoproteins and the Actions of Psychostimulants," which will be a subcontract carried out at Yale University School of Medicine, will study the role of Rap GTPase, and its modulators Rap1GAP and Epac2 in the actions of psychostimulants, as well as study the role of novel isoforms of PP2A in the actions of psychostimulants. Results from the three Projects will complement each other. In addition, there will be a significant level of collaboration between the three Projects, as well as close interaction of the three Projects with the Scientific Core.
Together the three Projects of the Program Project Grant will carry out innovative research that will lead to elucidation of the molecular pathways through which drugs of abuse act in the brain, and to an increased likelihood that therapeutic agents will be developed that will prevent or reverse molecular adaptations within these pathways.
|Colangelo, Christopher M; Ivosev, Gordana; Chung, Lisa et al. (2015) Development of a highly automated and multiplexed targeted proteome pipeline and assay for 112 rat brain synaptic proteins. Proteomics 15:1202-14|
|Wan, Xun; Torregrossa, Mary M; Sanchez, Hayde et al. (2014) Activation of exchange protein activated by cAMP in the rat basolateral amygdala impairs reconsolidation of a memory associated with self-administered cocaine. PLoS One 9:e107359|
|Kitchen, Robert R; Rozowsky, Joel S; Gerstein, Mark B et al. (2014) Decoding neuroproteomics: integrating the genome, translatome and functional anatomy. Nat Neurosci 17:1491-9|
|Arango-Lievano, Margarita; Schwarz, Justin T; Vernov, Mary et al. (2014) Cell-type specific expression of p11 controls cocaine reward. Biol Psychiatry 76:794-801|
|Dupré, Aude; Daldello, Enrico M; Nairn, Angus C et al. (2014) Phosphorylation of ARPP19 by protein kinase A prevents meiosis resumption in Xenopus oocytes. Nat Commun 5:3318|
|Meyer, Douglas A; Torres-Altoro, Melissa I; Tan, Zhenjun et al. (2014) Ischemic stroke injury is mediated by aberrant Cdk5. J Neurosci 34:8259-67|
|Magupalli, Venkat G; Mochida, Sumiko; Yan, Jin et al. (2013) Ca2+-independent activation of Ca2+/calmodulin-dependent protein kinase II bound to the C-terminal domain of CaV2.1 calcium channels. J Biol Chem 288:4637-48|
|Oh, Yong-Seok; Gao, Pu; Lee, Ko-Woon et al. (2013) SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. Cell 152:831-43|
|Yamagata, Yoko; Kaneko, Koichi; Kase, Daisuke et al. (2013) Regulation of ERK1/2 mitogen-activated protein kinase by NMDA-receptor-induced seizure activity in cortical slices. Brain Res 1507:1-10|
|Rebholz, Heike; Zhou, Mingming; Nairn, Angus C et al. (2013) Selective knockout of the casein kinase 2 in d1 medium spiny neurons controls dopaminergic function. Biol Psychiatry 74:113-21|
Showing the most recent 10 out of 179 publications